AGP Executive Report
Last update: 23 minutes agoCross-border care push (Hong Kong): Bupa Hong Kong launched “Bupa Care Bridge,” an affordable plan built for people who split life between Hong Kong and Mainland China, with inpatient coverage across both and outpatient/preventive care anchored in Hong Kong. Digital health for seniors (Hong Kong): The eHealth app is getting a simpler “Lite Mode” and easier features, after only 46% of registered seniors had activated the app—plus community support stations and home visits to boost uptake. Faster drug access (Hong Kong): Hong Kong’s new medical watchdog setup is expected to let mainland innovative drugmakers apply for SAR registration while also using National Medical Products Administration registration, aiming to speed market entry. Macau public health & policy: Macau is trialing a three-sided open-air smoking booth as smoke-free zones expand, while the Health Bureau continues monitoring a hantavirus situation tied to an Atlantic cruise ship. Drug pipeline momentum (region): Vincentage Pharma reported positive Phase 3 top-line results for VCT220 in overweight/obese Chinese adults, and Fosun Pharma and AriBio signed an exclusive global option deal for Alzheimer’s candidate AR1001.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.